J
Jun Zhang
Researcher at University of Kansas
Publications - 127
Citations - 3093
Jun Zhang is an academic researcher from University of Kansas. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 24, co-authored 108 publications receiving 2055 citations. Previous affiliations of Jun Zhang include Louisiana State University & Roy J. and Lucille A. Carver College of Medicine.
Papers
More filters
Journal ArticleDOI
O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Joshua D. Schoenfeld,Zita A. Sibenaller,Kranti A. Mapuskar,Brett A. Wagner,Kimberly L. Cramer-Morales,Muhammad Furqan,Sonia Sandhu,Thomas L. Carlisle,Mark C. Smith,Taher Abu Hejleh,Daniel J. Berg,Jun Zhang,John Keech,Kalpaj R. Parekh,Sudershan K. Bhatia,Varun Monga,Kellie L. Bodeker,Logan Ahmann,Sandy Vollstedt,Heather Brown,Erin P. Shanahan Kauffman,Mary E. Schall,Raymond J. Hohl,Gerald H. Clamon,Jeremy D.W. Greenlee,Matthew A. Howard,Michael K. Schultz,Brian J. Smith,Dennis P. Riley,Frederick E. Domann,Joseph J. Cullen,Garry R. Buettner,John M. Buatti,Douglas R. Spitz,Bryan G. Allen +34 more
TL;DR: It is shown that alterations in cancer cell mitochondrial oxidative metabolism resulting in increased levels of O2⋅- and H2O2 are capable of disrupting intracellular iron metabolism, thereby selectively sensitizing non-small-cell lung cancer and glioblastoma cells to ascorbate through pro-oxidant chemistry involving redox-active labile iron and H 2O2.
Journal ArticleDOI
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer
Sha Zhao,Shengxiang Ren,Tao Jiang,Bo Zhu,Xuefei Li,Chao Zhao,Yijun Jia,Jinpeng Shi,Limin Zhang,Xiaozhen Liu,Meng Qiao,Xiaoxia Chen,Chunxia Su,Hui Yu,Caicun Zhou,Jun Zhang,D. Ross Camidge,Fred R. Hirsch,Fred R. Hirsch +18 more
TL;DR: This work demonstrated that low-dose apatinib alleviated hypoxia, increased infiltration of CD8+ T cells, reduced recruitment of tumor-associated macrophages in tumor and decreased TGFβ amounts in both tumor and serum, which shows the rationale for the treatment of lung cancer with a combination of PD-1/PD-L1 blockade and low- dose apatinIB.
Journal ArticleDOI
Antibacterial Dental Composites with Chlorhexidine and Mesoporous Silica
TL;DR: This research has demonstrated the successful application of MSNs as a novel nanotechnology in dental materials to inhibit oral biofilm without sacrificing materials’ mechanical properties and surface integrity.
Journal ArticleDOI
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Yan Wang,Tao Jiang,Z. Qin,J. Jiang,Q. Wang,Shuo Yang,Christopher J. Rivard,Guanghui Gao,Terry L. Ng,Megan M. Tu,Hui Yu,Hongbin Ji,Caicun Zhou,Shengxiang Ren,Shengxiang Ren,Jun Zhang,Paul A. Bunn,Robert C. Doebele,D.R. Camidge,Fred R. Hirsch +19 more
TL;DR: Pyrotinib showed activity against NSCLC with HER2 exon 20 mutations in both patient-derived organoids and a PDX model and showed promising efficacy in the clinical trial.
Journal ArticleDOI
Three-dimensional endoscopic optical coherence tomography by use of a two-axis microelectromechanical scanning mirror
TL;DR: In this article, a dual-axis scanning microelectromechanical system (MEMS) mirror was used for 3D endoscopic optical coherence tomography (OCT).